{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:24:48Z","timestamp":1741238688778,"version":"3.38.0"},"reference-count":36,"publisher":"JLE","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.nephro.2019.02.005","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T07:17:22Z","timestamp":1554880642000},"page":"S85-S89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S1","title":["APOL1 risk genotype in Europe: Data in patients with focal segmental glomerulosclerosis and after renal transplantation"],"prefix":"10.1684","volume":"15","author":[{"given":"Aude","family":"Servais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Gribouval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Antignac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"issue":"10","key":"10.1016\/j.nephro.2019.02.005_bib0185","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ng.232","article-title":"MYH9 is associated with nondiabetic end-stage renal disease in African Americans","volume":"40","author":"Kao","year":"2008","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.nephro.2019.02.005_bib0190","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ng.226","article-title":"MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis","volume":"40","author":"Kopp","year":"2008","journal-title":"Nat Genet"},{"issue":"5993","key":"10.1016\/j.nephro.2019.02.005_bib0195","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.nephro.2019.02.005_bib0200","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.nephro.2019.02.005_bib0205","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1681\/ASN.2013111242","article-title":"Clinical features and histology of apolipoprotein L1-associated nephropathy in the FSGS clinical trial","volume":"26","author":"Kopp","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.nephro.2019.02.005_bib0210","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"issue":"1","key":"10.1016\/j.nephro.2019.02.005_bib0215","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ki.2012.263","article-title":"Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans","volume":"83","author":"Lipkowitz","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.02.005_bib0220","article-title":"APOL1 risk genotype in European steroid-resistant nephrotic syndrome and\/or focal segmental glomerulosclerosis patients of different African ancestries","author":"Gribouval","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.nephro.2019.02.005_bib0225","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrneph.2013.34","article-title":"APOL1 variants and kidney disease in people of recent African ancestry","volume":"9","author":"Genovese","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"10.1016\/j.nephro.2019.02.005_bib0230","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease","volume":"22","author":"Friedman","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.nephro.2019.02.005_bib0235","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1681\/ASN.2014111131","article-title":"Integrative genomics identifies novel associations with APOL1 risk genotypes in black NEPTUNE subjects","volume":"27","author":"Sampson","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.nephro.2019.02.005_bib0240","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/ki.2012.217","article-title":"Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease","volume":"82","author":"Freedman","year":"2012","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.nephro.2019.02.005_bib0245","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.ackd.2014.06.005","article-title":"APOL1 kidney risk alleles: population genetics and disease associations","volume":"21","author":"Limou","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.nephro.2019.02.005_bib0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gde.2016.08.005","article-title":"The African diaspora: history, adaptation and health","volume":"41","author":"Rotimi Ch","year":"2016","journal-title":"Curr Opin Genet Dev"},{"issue":"3","key":"10.1016\/j.nephro.2019.02.005_bib0255","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1053\/j.ajkd.2017.10.013","article-title":"HLA-DQA1 and APOL1 as risk loci for childhood-onset steroid-sensitive and steroid-resistant nephrotic syndrome","volume":"71","author":"Adeyemo","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.nephro.2019.02.005_bib0260","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1681\/ASN.2016111262","article-title":"Identifying the intracellular function of ApoL1","volume":"28","author":"Bruggeman","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.nephro.2019.02.005_bib0265","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1600-6143.2012.04033.x","article-title":"The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival","volume":"12","author":"Lee","year":"2012","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.nephro.2019.02.005_bib0270","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 gene and allograft survival after kidney transplantation","volume":"11","author":"Reeves-Daniel","year":"2011","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.nephro.2019.02.005_bib0275","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/ajt.13223","article-title":"Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure","volume":"15","author":"Freedman","year":"2015","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.nephro.2019.02.005_bib0280","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/TP.0000000000000969","article-title":"APOL1 genotype and kidney transplantation outcomes from deceased African American donors","volume":"100","author":"Freedman","year":"2016","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.nephro.2019.02.005_bib0285","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.ajkd.2018.05.008","article-title":"Donor's APOL1 risk genotype and \u201csecond hits\u201d associated with de novo collapsing glomerulopathy in deceased donor kidney transplant recipients: a report of 5 cases","volume":"73","author":"Chang","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.nephro.2019.02.005_bib0290","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.kint.2018.06.024","article-title":"Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts","volume":"94","author":"Santoriello","year":"2018","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.nephro.2019.02.005_bib0295","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM199508103330601","article-title":"High survival rates of kidney transplants from spousal and living unrelated donors","volume":"333","author":"Terasaki","year":"1995","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.nephro.2019.02.005_bib0300","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.2013.285141","article-title":"Risk of end-stage renal disease following live kidney donation","volume":"311","author":"Muzaale","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.nephro.2019.02.005_bib0305","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2013.460","article-title":"Long-term risks for kidney donors","volume":"86","author":"Mjoen","year":"2014","journal-title":"Kidney Int"},{"issue":"21","key":"10.1016\/j.nephro.2019.02.005_bib0310","first-page":"2094","article-title":"Kidney-failure risk projection for the living kidney-donor candidate","volume":"374","author":"Grams","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.nephro.2019.02.005_bib0315","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-6143.2012.04303.x","article-title":"Medical outcomes in African American live kidney donors: a matched cohort study","volume":"13","author":"Doshi","year":"2013","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.nephro.2019.02.005_bib0320","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/SLA.0000000000002174","article-title":"Apolipoprotein L1 and chronic kidney disease risk in young potential living kidney donors","volume":"267","author":"Locke","year":"2018","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.nephro.2019.02.005_bib0325","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1111\/ajt.14035","article-title":"Apol1-associated end-stage renal disease in a living kidney transplant donor","volume":"16","author":"Zwang","year":"2016","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.nephro.2019.02.005_bib0330","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1053\/j.ajkd.2013.12.014","article-title":"APOL1 polymorphisms and development of CKD in an identical twin donor and recipient pair","volume":"63","author":"Kofman","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.nephro.2019.02.005_bib0335","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1681\/ASN.2017060658","article-title":"APOL1 genotype and renal function of black living donors","volume":"29","author":"Doshi","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"8S Suppl 1","key":"10.1016\/j.nephro.2019.02.005_bib0340","first-page":"S1","article-title":"KDIGO clinical practice guideline on the evaluation and care of living kidney donors","volume":"101","author":"Lentine","year":"2017","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.nephro.2019.02.005_bib0345","doi-asserted-by":"crossref","first-page":"e462","DOI":"10.1097\/TP.0000000000002405","article-title":"Comparison of postdonation kidney function between caucasian donors and low-risk APOL1 genotype living kidney donors of African ancestry","volume":"102","author":"Gaillard","year":"2018","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.nephro.2019.02.005_bib0350","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2215\/CJN.12731215","article-title":"Association of mGFR of the remaining kidney divided by its volume before donation with functional gain in mGFR among living kidney donors","volume":"11","author":"Courbebaisse","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.nephro.2019.02.005_bib0355","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ar.1092320205","article-title":"Glomerular number and size in relation to age, kidney weight, and body surface in normal man","volume":"232","author":"Nyengaard","year":"1992","journal-title":"Anat Rec"},{"issue":"4","key":"10.1016\/j.nephro.2019.02.005_bib0360","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1067\/mob.2003.245","article-title":"Racial disparities in reproductive health outcomes","volume":"188","author":"Anachebe","year":"2003","journal-title":"Am J Obstet Gynecol"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725519300136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725519300136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2019.02.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:21:14Z","timestamp":1741191674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725519300136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":36,"alternative-id":["S1769725519300136"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2019.02.005","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOL1 risk genotype in Europe: Data in patients with focal segmental glomerulosclerosis and after renal transplantation","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2019.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}